CSF2 and nevoid basal cell carcinoma syndrome: The IPA core analysis of the 812 differentially regulated genes common to both BCNS and normal keratinocytes after rapamycin treatment predicted CDKN1A, KDM5B, let-7 and PTEN to be activated upstream regulators while CSF2 to be inhibited.